Kevin J. Reagan is Senior VP - Biotech at BIO-TECHNE Corp (TECH). They have made 1 open-market trade across 1 company since 2014, most recently 2014-12-09.
CIK 0001278790
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TECH | 2,591 | $188K |
Shares reported on the most recent Form 4, priced at the 2014-12-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TECH | SELL | 2014-12-05 | 2014-12-09 | $89.35 | $321K | -7.5% | -0.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.